Meet the team
Team
Jonathan Irwin
JD, LLM, MBA
Jonathan Irwin is CEO of AmebaGone. He has a background in biotechnology and extensive experience at the executive level in multiple startups.
Courtney Griese
B.S.
Courtney Griese joined Amebagone in 2017. She holds a B.S. in Microbiology from the University of Wisconsin-Madison.
Noah Stern
Ph.D.
Dr. Stern leads agricultural research efforts at AmebaGone. He received his Ph.D. in Environmental Chemistry and Technology at the University of Wisconsin.
Nathan Chesmore
Ph.D.
Dr. Chesmore received his Ph.D. at the University of Wisconsin-Madison in the Department of Animal Sciences. His doctoral dissertation was the first to reveal the anti-biofilm strategy of Dicty and focused on the fractionation of Dicty compounds produced during their predation on bacteria.
Scientific Advisors
Michael Bentz
MD
Vice Chairman of Clinical Affairs, Dept. of Surgery, Chair, Division of Plastic and Reconstructive Surgery, University of Wisconsin-Madison School of Medicine and Public Health
John C. Landolt
Ph.D.
Professor Emeritus, Plant Biology, Shepherd University, West Virginia
Curtis Brant
Ph.D.
Professor of Ophthalmology and Visual Sciences, Medical Microbiology and Immunology and the Clinical Cancer Center, University of Wisconsin-Madison School of Ophthalmology
Richard Proctor
Ph.D.
Professor Emeritus, Department of Medicine and Microbiology, University of Wisconsin-Madison. Retired Global Director for Infectious Diseases for Antibiotics and Antifungals, Merck
Business Advisors
David Casimir
JD, Ph.D.
Shareholder, Casimir and Jones
Founder
Marcin Filutowicz
1950 - 2022
Ph.D.
Marcin Filutowicz founded AmebaGone in 2010 with the goal of commercializing the use of amoebae for biocontrol and disease treatment.